0000921895-22-000230.txt : 20220124 0000921895-22-000230.hdr.sgml : 20220124 20220124173035 ACCESSION NUMBER: 0000921895-22-000230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220124 FILED AS OF DATE: 20220124 DATE AS OF CHANGE: 20220124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eberwein Jeffrey E. CENTRAL INDEX KEY: 0001548312 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35947 FILM NUMBER: 22550481 MAIL ADDRESS: STREET 1: 53 FOREST AVENUE, 1ST FLOOR CITY: OLD GREENWICH STATE: CT ZIP: 06870 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STAR EQUITY HOLDINGS, INC. CENTRAL INDEX KEY: 0000707388 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330145723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FOREST AVENUE CITY: OLD GREENWICH STATE: CT ZIP: 06870 BUSINESS PHONE: 203-489-9501 MAIL ADDRESS: STREET 1: 13100 GREGG STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 FORMER COMPANY: FORMER CONFORMED NAME: DIGIRAD CORP DATE OF NAME CHANGE: 19821006 4 1 form409271ebe_01242022.xml OWNERSHIP DOCUMENT X0306 4 2022-01-24 0 0000707388 STAR EQUITY HOLDINGS, INC. STRR 0001548312 Eberwein Jeffrey E. C/O STAR EQUITY HOLDINGS, INC. 53 FOREST AVENUE SUITE 101 OLD GREENWICH CT 06870 1 1 1 0 Executive Chairman Common Stock 2022-01-24 4 P 0 1075000 1.49 A 1923290 D 10% Series A Cumulative Perpetual Preferred Stock 1289978 D Warrant 1.50 2022-01-24 4 P 0 1075000 0.01 A 2022-01-24 2027-01-24 Common Stock 1075000 1075000 D The Reporting Person purchased the shares of common stock and the warrants reported on this Form 4 directly from the underwriter in an underwritten public offering conducted by the Issuer that closed on January 24, 2022. Each share of common stock was sold together with one warrant to purchase one share of common stock at a price of $1.50 per share and warrant, of which the price per share for common stock was $1.49 and the price per warrant was $0.01. /s/ Jeffrey E. Eberwein 2022-01-24